Author | Age & sex, site | Onset | Diagnosis, site | EBV status | Treatment | Follow up |
---|---|---|---|---|---|---|
Doak et al 1968 | 34 ♂, kidney | 180 days | Reticular Cell Sarcoma, tongue & oral cavity | Viral inclusions | Antimycotic Medication NOS | Died 30 days after |
Staddlemann et al 1996 | 65 ♀, kidney | 600 days | NK/T-cell lymphoma, pharynx | Positive | Cyclosporine d/c, Four cycles CHOP | Remission for 1080 days |
Reams et al 2003 | 16 ♀, R + L lung | 330 days | Polymorphic B-cell lymphoma, tongue | Negative | Four cycles of Rituximab | Patient died of Sepsis |
Rolland et al 2004 | 60 ♂, heart | 3600 days | Peripheral T-cell lymphoma NOS, gingiva | Positive | Azathioprine d/c, decrease Cyclosporin | Remission for 360 days |
Rolland et al 2004 | 61 ♂, heart | 1410 days | DLBCL, maxilla | Posotive | Stepwise decrease in Ciclosporin | Recurrences at 180 and 510 days |
Bruce et al 2006 | 45 ♀, pancreas | 660 days | DLBCL, tongue | Positive | Sirolimus d/c Tacrolimus adjusted | Remission 660 days, AR |
Gonzalez-Cuyar et al 2007 | 47, ♂, kidney pancreas | 720 days | DLBCL, tongue | Positive | Decreased immunosupression | Remission for 790 days |